Global Pharma Manufacturing Summit 2011

Overview:

The 6th Annual Global Pharma Manufacturing Summit is a networking opportunity for industry leaders involved in small molecule and biologic pharma manufacturing to discuss the current challenges and new strategies to remain competitive, reduce waste, streamline processes and increase their global presence.

Program highlights include:

• Employing robust processes and systems in a changing regulatory climate: Exploring the need to fully characterize existing processes before employing a more robust production strategy led by Jacks Lee, VP Vaccines, Biologics & Sterile Pharmaceutical Operations, Merck & Co

• Restructuring operations to achieve operational excellence: Aligning manufacturing, development and quality functions to a common goal led by Jean-Francois Guilland, IQP Head BioPharmOps, Novartis Pharma

• Implementing innovative protocols in flexible manufacturing, capacity utilization, new technologies and disposables led by Mike Kinley, Senior Director Operations, MedImmune

• Bristol-Myers Squibb case study: Creating a multi-disciplinary QBD roadmap: A pilot collaboration with the FDA led by Dr Tobias Massa, VP Global Regulatory Sciences, Chemistry Manufacturing and Control, Bristol-Myers Squibb

• Continuous manufacturing in pharma – impact on development and production: Opportunities, Challenges, Trend and Drivers led by Dr Norbert Rasenack, Fellow Pharmaceutical Development, Novartis Pharma

• Validating old and new processes in remaining CGMP regulation compliant: Effectively managing process quality to ensure changing regulatory expectations are met led by David Kahn, Senior Director Biopharmaceutical Development, Human Genome Sciences

View the latest program Here >>> http://www.gpmsummit.com/program

Book your place as a delegate today for US$1995 at http://www.gpmsummit.com/booknow